bis(diazoacetyl)butane: russian drug [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 15061 |
| MeSH ID | M0041831 |
| Synonym |
|---|
| 1,4-bis(diazoacetyl)butane |
| 1448-16-4 |
| 1,4-bis-diazoacetylbutane |
| supermutagen |
| 2,7-octanedione, 1,8-bis(diazo)- |
| dab (mutagen) |
| 1,4-bisdiazoacetylbutane |
| bis(diazoacetyl)butane |
| AKOS001025491 |
| 1,8-bis(diazo)octane-2,7-dione |
| STL334255 |
| DTXSID8074524 |
| 1,8-didiazooctane-2,7-dione |
| Z56755545 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||